mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.064 |
0.8 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |